Inventor · disambiguated record
Sandro Belvedere
Also filed as: BELVEDERE SANDRO
22 granted patents·11 pending applications·322 citations·filing 2000–2024
95Inventor score
Top patents by PatentIndex Score
33 records- 0198US6511990B1Class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereofSLOAN KETTERING INST CANCER·Filed 2000·Granted Jan 28, 2003·213 cites·35 claims
- 0293US7683056B2Pyridine derivatives and their use in the treatment of psychotic disordersGLAXOSMITHKLINE LLC·Filed 2006·Granted Mar 23, 2010·19 cites·12 claims
- 0392US11504383B2Crystalline forms of a Ryanodine receptor modulator and uses thereofARMGO PHARMA INC·Filed 2022·Granted Nov 22, 2022·4 cites·24 claims
- 0489US7507858B2Histone deacetylase inhibitorsMERCK & CO INC·Filed 2005·Granted Mar 24, 2009·13 cites·11 claims
- 0588US7345174B2Cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereofSLOAN KETTERING INST CANCER·Filed 2006·Granted Mar 18, 2008·6 cites·9 claims
- 0688US7126001B2Class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereofUNIV COLUMBIA·Filed 2002·Granted Oct 24, 2006·16 cites·11 claims
- 0785US8129384B2Imidazo[1,2-a]pyrazines as orexin receptor antagonistsALVARO GIUSEPPE·Filed 2009·Granted Mar 6, 2012·7 cites·17 claims
- 0885US8093255B2Imidazo[1,2-A]pyrimidines as orexin receptor antagonistsALVARO GIUSEPPE·Filed 2009·Granted Jan 10, 2012·8 cites·17 claims
- 0984US7919491B2Pyridine derivatives and their use in the treatment of psychotic disordersGLAXOSMITHKLINE LLC·Filed 2009·Granted Apr 5, 2011·4 cites·6 claims
- 1082US8853198B2Agents for treating disorders involving modulation of ryanodine receptorsSERVIER LAB·Filed 2013·Granted Oct 7, 2014·8 cites·29 claims
- 1179US8618282B2Process for preparing benzothiazepines from gamma-aminoalkylbenzenesDENG SHIXIAN·Filed 2009·Granted Dec 31, 2013·4 cites·33 claims
- 1278US8097618B2Pyridine derivatives and their use in the treatment of psychotic disordersALVARO GIUSEPPE·Filed 2011·Granted Jan 17, 2012·3 cites·6 claims
- 1377US8227636B2Histone deacetylase inhibitor prodrugsMILLER THOMAS A·Filed 2005·Granted Jul 24, 2012·3 cites·30 claims
- 1477US7795304B2Histone deacetylase inhibitorsMERCK SHARP & DOHME·Filed 2005·Granted Sep 14, 2010·3 cites·13 claims
- 1577US7737184B2Histone deacetylase inhibitorsMERCK SHARP & DOHME·Filed 2005·Granted Jun 15, 2010·3 cites·15 claims
- 1677US7199134B2Hydroxamic acid compounds and methods of use thereofUNIV COLUMBIA·Filed 2004·Granted Apr 3, 2007·8 cites·38 claims
- 1776US2025170144A1Crystalline forms of a ryanodine receptor modulator and uses thereofRYCARMA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1874US12076327B2Crystalline forms of a ryanodine receptor modulator and uses thereofARMGO PHARMA INC·Filed 2022·Granted Sep 3, 2024·0 cites·23 claims
- 1974US12076326B2Crystalline forms of a ryanodine receptor modulator and uses thereofARMGO PHARMA INC·Filed 2022·Granted Sep 3, 2024·0 cites·25 claims
- 2061US2023399324A1Agents for treating disorders involving ryanodine receptorsARMGO PHARMA INC·Filed 2023·Application pending·0 cites
- 2160US9573914B2Process for preparing benzothiazepines from gamma-aminoalkylbenzenesSERVIER LAB·Filed 2013·Granted Feb 21, 2017·0 cites·22 claims
- 2259US7799803B2Hydroxamic acid compounds and methods of use thereofUNIV COLUMBIA·Filed 2007·Granted Sep 21, 2010·0 cites·10 claims
- 2357US2009022670A1Novel compoundsALVARO GIUSEPPE·Filed 2008·Application pending·0 cites
- 2456US2010267730A1Novel compoundsALVARO GIUSEPPE·Filed 2009·Application pending·0 cites
- 2555US2023416228A1Agents for the treatment of diseases by inhibition of foxo1FORKHEAD BIOTHERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2653US2014378437A1Agents for treating disorders involving modulation of ryanodine receptorsSERVIER LAB·Filed 2014·Application pending·0 cites
- 2752US2013281512A1Agents for treating disorders involving modulation of ryanodine receptorsSERVIER LAB·Filed 2013·Application pending·0 cites
- 2849US2010210667A1Imidazo [1, 2-c] pyrimidin-2-ylmethylpiperidines as orexin receptor antagonistsALVARO GIUSEPPE·Filed 2008·Application pending·0 cites
- 2948US7935724B2Thiophene and benzothiophene hydroxamic acid derivativesMERCK HDAC RES LLC·Filed 2004·Granted May 3, 2011·0 cites·17 claims
- 3046US2011288098A1Novel compoundsALVARO GIUSEPPE·Filed 2011·Application pending·0 cites
- 3146US2022185797A1Selective foxo inhibitors for treatment of diabetes and other disorders related to impaired pancreatic functionTHE TRUSTEES OF COLUMBIA UNIV THE CITY OF NEW YORK·Filed 2020·Application pending·0 cites
- 3243US7534918B2Histone deacetylase inhibitorsMERCK & CO INC·Filed 2005·Granted May 19, 2009·0 cites·17 claims
- 3341US2009023718A1Diamine and Iminodiacetic Acid Hydroxamic Acid DerivativesATON PHARMA INC·Filed 2004·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Sandro Belvedere files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →